Literature DB >> 19998683

The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis.

Pamela K Newland1, Robert T Naismith, Margaret Ullione.   

Abstract

The purpose of this study was to assess pain, fatigue, depression, sleep disturbance, and quality of life (QOL) in women with relapsing-remitting multiple sclerosis (RRMS) compared with healthy controls. A prospective, cross-sectional, matched-control study was conducted in women with RRMS compared with healthy women. Compared with healthy women, women with RRMS had (a) greater pain presence over 7 days (67%), (b) higher pain intensity, and (c) more pain interference. Pain had a negative impact on fatigue, depression, and sleep in both groups. In all participants, fatigue, depression, and sleep disturbance contributed to decreased mental QOL (mental component summary of QOL scores). Pain has significant nursing implications for women with RRMS. Pain often occurs in association with fatigue, depression, and sleep disturbance, which can lead to a decreased mental QOL.

Entities:  

Mesh:

Year:  2009        PMID: 19998683      PMCID: PMC2901159          DOI: 10.1097/jnn.0b013e3181b6be96

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  36 in total

1.  Self-reported sleep disturbances in employed women.

Authors:  K A Lee
Journal:  Sleep       Date:  1992-12       Impact factor: 5.849

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study.

Authors:  C Miaskowski; K A Lee
Journal:  J Pain Symptom Manage       Date:  1999-05       Impact factor: 3.612

4.  Validity and reliability of a scale to assess fatigue.

Authors:  K A Lee; G Hicks; G Nino-Murcia
Journal:  Psychiatry Res       Date:  1991-03       Impact factor: 3.222

5.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

Review 6.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

7.  The short-form McGill Pain Questionnaire.

Authors:  Ronald Melzack
Journal:  Pain       Date:  1987-08       Impact factor: 6.961

8.  Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients.

Authors:  C J Archibald; P J McGrath; P G Ritvo; J D Fisk; V Bhan; C E Maxner; T J Murray
Journal:  Pain       Date:  1994-07       Impact factor: 6.961

Review 9.  Pain in central and peripheral demyelinating disorders.

Authors:  D E Moulin
Journal:  Neurol Clin       Date:  1998-11       Impact factor: 3.806

10.  The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study.

Authors:  C Solaro; G Brichetto; M P Amato; E Cocco; B Colombo; G D'Aleo; C Gasperini; A Ghezzi; V Martinelli; C Milanese; F Patti; M Trojano; E Verdun; G L Mancardi
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

View more
  13 in total

Review 1.  Review of Treatment for Central Spinal Neuropathic Pain and Its Effect on Quality of Life: Implications for Neuromyelitis Optica Spectrum Disorder.

Authors:  Maureen A Mealy; Sharon L Kozachik; Michael Levy
Journal:  Pain Manag Nurs       Date:  2019-05-15       Impact factor: 1.929

Review 2.  Co-occurring depression and pain in multiple sclerosis.

Authors:  Kevin N Alschuler; Dawn M Ehde; Mark P Jensen
Journal:  Phys Med Rehabil Clin N Am       Date:  2013-07-23       Impact factor: 1.784

3.  Role of environment and sex differences in the development of autoimmune diseases: a roundtable meeting report.

Authors:  Monica P Mallampalli; Erika Davies; Debra Wood; Hillary Robertson; Federica Polato; Christine L Carter
Journal:  J Womens Health (Larchmt)       Date:  2013-07       Impact factor: 2.681

4.  Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?

Authors:  Trishna Bharadia; Jo Vandercappellen; Tanuja Chitnis; Piet Eelen; Birgit Bauer; Giampaolo Brichetto; Andrew Lloyd; Hollie Schmidt; Miriam King; Jennifer Fitzgerald; Thomas Hach; Jeremy Hobart
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-06-22

Review 5.  Sleep Disorders in Multiple Sclerosis.

Authors:  Tiffany J Braley; Eilis Ann Boudreau
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

6.  Association of neuromyelitis optica with severe and intractable pain.

Authors:  Peiqing Qian; Samantha Lancia; Enrique Alvarez; Eric C Klawiter; Anne H Cross; Robert T Naismith
Journal:  Arch Neurol       Date:  2012-11

7.  The use of focus groups to characterize symptoms in persons with multiple sclerosis.

Authors:  Pamela K Newland; Florian P Thomas; Marguerite Riley; Louise H Flick; Arleen Fearing
Journal:  J Neurosci Nurs       Date:  2012-12       Impact factor: 1.230

8.  Poor sleep in patients with multiple sclerosis.

Authors:  Hanne Marie Bøe Lunde; Tommy F Aae; William Indrevåg; Jan Aarseth; Bjørn Bjorvatn; Kjell-Morten Myhr; Lars Bø
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 9.  Quality of life in multiple sclerosis.

Authors:  Józef A Opara; Krystyna Jaracz; Waldemar Brola
Journal:  J Med Life       Date:  2010 Oct-Dec

10.  Effect of COVID-19 home confinement on sleep monitorization and cardiac autonomic function in people with multiple sclerosis: A prospective cohort study✰,✰✰.

Authors:  Luis Andreu-Caravaca; Domingo Ramos-Campo; Pedro Manonelles; Oriol Abellán-Aynés; Linda H Chung; Jacobo Á Rubio-Arias
Journal:  Physiol Behav       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.